Hyperlipidemia
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-75 years; 2. Patients with dyslipidemia; 3. The cardiovascular risk was assessed as low risk patients; 4. Those who voluntarily participate in the research and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who were taking antilipidemic drugs within 3 months before inclusion; 2. Patients with nephrotic syndrome, hypothyroidism, renal failure, liver disease and systemic lupus erythematosus; 3. Patients with myeloma, glycogen accumulation, fatty atrophy, acute porphyria and polycystic ovary syndrome; 4. Patients taking drugs related to lipid metabolism, such as diuretics, beta blockers, glucocorticoids, metformin, insulin and contraceptives; 5. Patients whose systolic blood pressure is still >= 180mmhg or diastolic blood pressure is still >= 110mhg after treatment; 6. After oral drug treatment, the blood glucose is still >= 11.1mmol/L Of patients; 7. TG >= 5.65mmol/L Those who; 8. Patients with heart, liver, kidney, hematopoietic system, immune system and other systemic serious diseases; 9. Pregnant or lactating women or those who plan to be pregnant during the trial period or their spouses plan to be pregnant; 10. Patients with allergic constitution, possible allergy to the drug or psychosis; 11. Other patients who cannot cooperate for a long time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TG;TC;LDL-C;HDL-C; | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of blood lipid components meet the standard;BMI;GLU;UA;CRP; | — |
Countries
China
Contacts
Guangdong Province Traditional Chinese Medical Hospital